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Background: Mortality rate of patients admitted to Intensive Care Units is a widely adopted outcome indicator.
Because of large case-mix variability, comparisons of mortality rates must be adjusted for the severity of patient
illness at admission. The Pediatric Index of Mortality 2 (PIM-2) has been widely adopted as a tool for adjusting
mortality rate by patients’ case mix. The objective of this study was to assess the performance of PIM-2 in children
admitted to intensive care units after cardiac surgery, other surgery, or for other reasons.
Methods: This was a prospective cohort study, conducted in a 607 inpatient-bed tertiary-care pediatric hospital in
Italy, with three pediatric intensive care Units (PICUs) and one cardiac Unit (CICU). In 2009–11, all consecutive
admissions to PICUs/CICU of children aged 0–16 years were included in the study. Discrimination and calibration
measures were computed to assess PIM-2 performance. Multivariable logistic regression analysis was used to assess
the association of patients’ main reason for intensive care admission (cardiac-surgical, other-surgical, medical), age,
Unit and year with observed mortality, adjusting for PIM-2 score.
Results: PIM-2 data collection was completed for 91.2% of total PICUs/CICU patient admissions (2912), and for
94.8% of patients who died in PICUs/CICU (129). Overall observed mortality was 4.4% (95% CI, 3.7-5.2), compared to
6.4% (95% CI, 5.5-7.3) expected mortality. Standardised mortality ratio was 0.7 (95% CI: 0.6-0.8). PIM-2 discrimination
was fair (area under the curve, 0.79; 95% CI: 0.75-0.83). Calibration was less satisfactory, mainly because of the over
two-fold overprediction of deaths in the highest risk group (114.7 vs 53; p < 0.001), and particularly in cardiac-surgical
patients. Multivariable logistic analysis showed that risk of death was significantly reduced in cardiac-surgical patients and
in those aged 1 month to 12 years, independently from PIM-2.
Conclusions: The children age distribution and the proportion of cardiac-surgical patients should be taken into account
when interpreting SMRs estimated using the PIM-2 prediction model in different Units. A new calibration study of PIM-2
score might be needed, and more appropriate cardiac-focused risk-adjustment models should be developed. The role of
age on risk of death needs to be further explored.
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The mortality rate of patients admitted to Intensive Care
Units is a widely adopted outcome indicator, and in chil-
dren it was reported to vary from 3.8% to 13% in North
and South America and in Europe [1-4]. Because of
case-mix variability, comparisons of mortality between
different Units, and in the same Unit over time, must be
adjusted for the severity of patient illness at admission.
To this end, severity-scoring systems specific for the
pediatric population have been developed [5].
The Pediatric Index of Mortality 2 (PIM-2) score uses
a logistic regression model to obtain an equation that
describes the relationship between a limited set of pre-
dictor variables measured at the time of admission to
intensive care and the probability of death. Originally de-
veloped in Australia in the mid-1980’s [6], the score was
revised to version 2 in late 1990’s [7] to account for the
changes in intensive care organization and outcomes over
time. Since then, PIM-2 has been widely adopted as a tool
for adjusting mortality rate by patients’ case mix [8-10].
However, its performance has recently been questioned
for pediatric cardiac surgery patients, as a study carried
out in the United States showed that in this group
discrimination was lower than previously reported, and
calibration was poor [11]. Whether or not the same result
would be obtained in pediatric patients treated in a
specialized dedicated cardiac ICU was, according to the
Authors [11], an open question.
The Bambino Gesù Children’s Hospital is a 607
inpatient-beds tertiary care and research institute in
Rome, Italy, with one pediatric cardiac surgery Intensive
Care Unit (CICU) and three multidisciplinary medical/
surgical (M/S) pediatric Intensive Care Units (PICUs),
two of which participated in a national PIM-2 validation
study conducted in years 2004–2005 [10].
This study is aimed at assessing the performance of
PIM-2 in children admitted to the three PICUs and to
CICU after cardiac surgery, other surgical procedures, or
for other reasons.Methods
Setting
The Bambino Gesù Children’s Hospital is the largest
pediatric hospital in Italy, and a referral center for pediatric
cardiac surgery, pediatric trauma, organs and bone marrow
transplants and extracorporeal membrane oxygenation. An-
nual hospital acute inpatient admissions were 30,344 in
2009, 23,796 in 2010, and 24,449 in 2011. Over this period
the average diagnosis-related group weight at hospital dis-
charge, a measure of disease complexity, increased from
0.92 in 2009, to 1 in 2010 and 1.03 in 2011. The average
length of hospital stay also increased, being 5.9, 6.3 and
6.4 days from 2009 to 2011.The Bambino Gesù CICU (14 beds) is a dedicated
pediatric cardiac and cardiac surgical Unit. The three
M/S PICUs have a total of 23 beds; PICU1 and PICU3
mostly admit surgical patients, including transplants
(PICU1), and hospitalised patients who become critically
ill; PICU2 covers all the intensive care admission from
the Emergency Service and also neurosurgical patients.
All Intensive Care Units have their own medical and
nursing staff.
The collection and analysis of PIM-2 data for estimating
Standardised Mortality ratios (SMRs) in each Intensive
Care Unit was one of the objectives of the 2009–2011
annual Hospital Quality Improvement Programs. These
objectives are annually reviewed and approved by the
Hospital Quality Committee.
Data collection
All consecutive patient admissions to one of the four
hospital PICUs/CICU from 1 January 2009 to 31 December
2011 were included in the study. Preterm babies below
32 weeks of gestational age and/or birth weight < 1500
grams, and adolescents >16 years of age were excluded.
Patients re-admissions to PICU/CICU were included as
new admissions only if occurred ≥ 48 hours from transfer
to another hospital ward; otherwise they were considered
as one single admission [10].
Intensive care physicians prospectively collected the
data required for PIM-2 calculations [7] within one hour
from time of admission to PICU/CICU. Data on patient
age, gender, length of intensive care stay, outcome (dead/
alive) at discharge from PICU/CICU and ICD9 codes of
main diagnosis at discharge from hospital were abstracted
from patients’ medical record. The variable “main reason
for CICU/PICU admission” was created using information
on surgical procedures performed before transfer to inten-
sive care, and patient diagnosis at discharge. It was then
categorized in the following three groups: recovery from
cardiac surgical procedure (cardiac surgical patients);
recovery from other surgery (other surgical patients);
other reasons than recovery from surgery (medical pa-
tients). Patients still in the PICU at the end of the study
were considered alive.
Data analysis
All analyses were carried out at the level of the individual
admission to intensive care (unit of analysis).
Characteristics of patients consecutively admitted to
PICU/CICU were reported according to the type of
Intensive Care Unit. Differences were tested in univariate
analyses using the χ2 or Fisher exact tests for categorical
variables, and non parametric analysis (Kruskal Wallis test
for medians) for continuous variables.
Discrimination and calibration measures were used to
assess the PIM-2 performance. Discrimination, i.e. the
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tween survivors and non-survivors at discharge from
ICU, was assessed by computing the Receiver Operating
Characteristic (ROC) curve and underlying area (Area
Under the Curve; AUC) on the total sample and by Unit,
main reason of PICU/CICU admission (i.e., cardiac surgi-
cal, other surgical and medical), year and patient age class.
Age class was defined using the six-group classification
adopted by the International Sepsis Forum [12], i.e.,
newborn (< 7 days of life); neonate (7–30 days); infant (1–
12 months); pre-school (1–5 years); school (6–12 years);
adolescent (13–16 years). An AUC > 0.70 was considered
to indicate acceptable discriminatory performance [13].
Calibration, or agreement between the predicted and
the actual observed number of deaths, was measured using
the Hosmer-Lemeshow goodness-of-fit chi-squared test by
groups of predicted mortality risk, on the total sample and
by main reason of PICU/CICU admission. The Hosmer-
Lemeshow test was calculated as Σ (O - E)2/E, where O
is observed and E is expected (or PIM-2-standardized)
number of events in each group of risk [14]. For this
test, p value >0.05 indicates good calibration.
Standardised Mortality ratios (SMRs) and 95% confi-
dence intervals (CI) were computed as the number of
observed deaths divided by the deaths predicted by the
PIM-2 score. SMRs were calculated in the total sample,
by Unit, main reason of PICU/CICU admission, year
and age class.
A multivariable regression analysis was performed to
assess whether other variables could predict the risk of
death independently from PIM2 score. In detail, this
analysis simultaneously investigated the association be-
tween main reason for PICU/CICU admission, age class,
year of admission, type of Intensive Care Unit and ob-
served mortality, adjusting for PIM-2 score. The final
model retained all the variables significantly associated
with mortality at p < 0.05 level.
Data analyses were performed using the STATA statis-
tical package, version 12 (Stata Corp, College Station, TX).Results
During the study period, there were a total of 3,194
patient admission to PICUs/CICU. PIM-2 data were
completed for 91.2% of admissions (n = 2,912). In 282
admissions PIM2 score could not be computed because
of missing values.
CICU contributed to 46.6% of cases (Table 1). Com-
pared to admissions to the three PICUs, CICU admis-
sions involved younger patients (about 23% ≤ 30 days of
life). In > 90% of cases they were affected by cardiovascular
congenital malformations or cardiovascular diseases; 81%
were admitted to CICU after cardiac surgical procedures,
while the other cases did not report recovery from cardiacsurgery as main reason for CICU admissions. In con-
trast, PICU3 admissions concerned older patients (about
59% ≥6 years of age), mostly affected by diseases of the
musculoskeletal (39.6%) or respiratory (24.3%) systems.
Over 77% of them were admitted to PICU after surgical
procedures other than cardiac. In the other two PICUs, re-
spiratory diseases were the most frequent main discharge
diagnosis (31.4 and 28.2% respectively), followed by cancer
(12.8%) and gastro-intestinal disorders (10.2%) in PICU1,
and by diseases of the nervous system and sense organs
(18.4%), injuries and poisonings (12.9%) in PICU2. In those
two PICUs, other surgical and medical PICU admissions
were evenly distributed.
Overall, 174 patients were readmitted to the same
PICU/CICU > 48 hours from being transferred to an-
other hospital ward, accounting for a total number of
387 admissions (13% of the 2,912 admissions considered,
data not shown in table). These children experienced a
median number of 2 admissions per patient (range: 2–5).
The main reason for PICU/CICU admission was cardiac
surgical for the majority of cases (169/387, 43.7%),
followed by medical (130; 33.6%) and other surgical (88;
22.7%). Median length of stay in PICU/CICUs was 4 days
per admission (range: 0–244 days).
In the years 2009–2011, 136 patients died in PICUs/
CICU; PIM-2 was collected for 129/136 (94.8%). The
seven patients who died and had no PIM-2 data were
admitted in PICU/CICU for medical causes (four patients,
aged 5, 10, 12 and 13 years, respectively) or for other
surgical procedures (three patients aged 11, 14 and
15 years respectively).
Table 2 shows the observed and PIM-2-standardized
(expected) mortality rates by Unit type, patients’ charac-
teristics, and year. Overall the observed mortality was
4.4% (95% CI, 3.7-5.2), but varied significantly according
to reason for intensive care admission (p < 0.001), and
patient age class (p < 0.001).
The total number of expected deaths was 186.4, ac-
counting for a PIM-2 predicted mortality risk of 6.4%
(95% CI, 5.5-7.3) and SMR of 0.7 (95% CI, 0.6-0.8). The
number of observed deaths was significantly lower than
expected in CICU and PICU1, as indicated by SMR
confidence limits both below 1. The SMR was < 1 also in
PICU3 (0.6), but this result was not statistically signifi-
cant (95% CI: 0.3-1.2).
Compared to expected, observed mortality was signifi-
cantly lower also in cardiac surgical and medical admis-
sions, while numbers of observed and expected deaths
were very close in the other surgical group (28 vs 26.4;
SMR 1.1). Mortality rates and SMRs remained stable
over the three years of the study.
Overall, the value of the area under the curve (AUC)
was 0.79 (95% CI, 0.75-0.83), indicating good discrim-
ination ability. The full ROC curve for the total sample
Table 1 Characteristics of patients admissions to intensive care unit, by type of unit
CICU PICU 1 PICU 2 PICU 3 Total
(N. 1,356) (N. 538) (N. 697) (N. 321) (N. 2,912)
N % N % N % N % P-value N %
Gender < 0.001
Male 743 54.9 300 56.2 436 62.6 137 43.0 1,616 55.7
Female 611 45.1 234 43.8 261 37.5 182 557.0 1,288 44.3
Age class < 0.001
Newborn (0-7d) 188 13.9 20 3.7 43 6.2 0 0.0 251 8.6
Neonate (8–30 d) 125 9.2 12 2.3 35 5.0 3 0.9 175 6.0
Infant (1–12 m) 409 30.2 141 26.2 214 26.3 49 15.2 813 27.9
Preschool (1–5 y) 378 27.9 204 37.9 256 27.9 79 24.6 917 31.5
School (6–12 y) 170 12.5 112 20.8 81 18.7 70 21.8 433 14.9
Adolescent (13-16y) 86 6.3 49 9.1 68 21.1 120 37.4 323 11.1
Elective admissions in PICU/CICU < 0.001
No 171 12.6 333 61.9 389 55.8 66 20.6 959 32.9
Yes 1185 87.4 205 38.1 308 44.2 255 79.4 1,953 67.1
Main reason for PICU/CICU admission < 0.001
Cardiac surgical 1100 81.1 12 2.2 20 2.9 8 2.5 1,140 39.2
Other surgical 106 7.8 248 46.1 349 50.1 249 77.6 952 32.7
Medical 150 11.1 278 51.7 328 47.1 64 19.9 820 28.2
Length of stay in PICU/CICU Median (Range) 2 (0.0 – 564.0) 3 (0.0; 220.0) 3 (0.0; 111.0) 1 (0.0 – 365.0) < 0.001 2 (0.0 – 564.0)
Main Diagnosis at Hospital discharge < 0.001
Congenital anomalies and other diseases of the circulatory system 1,229 90.6 41 7.6 34 4.9 9 2.8 1,313 45.1
Diseases of the respiratory system 18 1.3 169 31.4 201 28.2 78 24.3 466 16.0
Diseases of the nervous system of the sense organs 5 0.4 38 7.1 128 18.4 16 5.0 187 6.4
Injury and poisoning 67 4.9 13 2.4 90 12.9 4 1.3 174 5.6
Diseases of the musculoskeletal system and connective tissue 1 0.1 0 0.0 0 0.0 127 39.6 128 4.4
Diseases of the digestive system 4 0.3 55 10.2 23 3.3 28 8.7 110 3.8
Infectious and parasitic diseases 1 0.1 13 2.4 11 1.6 0 0 25 0.9
Congenital anomalies other than circulatory system 8 0.6 56 10.4 54 7.8 33 10.3 151 5.2
Cancer 6 0.4 69 12.8 69 9.9 12 3.7 156 5.4
Other 17 1.3 84 15.6 87 12.5 14 4.4 202 6.9
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over 0.70 for all reasons of admission to intensive care,
though it was lowest among the cardiac surgical and
highest among the other surgical patients (Table 2).
The Hosmer-Lemeshow test showed a suboptimal
overall goodness of fit (129 observed versus 186.4
expected deaths; p < 0.001) (Table 3). This result was
mainly due to the overprediction of deaths in the highest
risk centile (53 versus 114.7, SMR 0.5, 95% CI 0.4-0.6).
Overprediction of deaths in the highest risk group was
confirmed for cardiac surgical (11 observed vs 43.8
expected deaths) and medical patients (27 observed vs
45.4 expected deaths), but was not present in the other
surgical patients (results not shown in table).The multivariable logistic analysis showed that, inde-
pendently from PIM-2, main reason of PICU/CICU ad-
mission and patients’ age remained significantly
associated with observed mortality, while year and Unit
were not (Table 4). Compared to medical patients, car-
diac surgical patients had a significantly lower risk of
deaths. Babies in the first month of life and adolescents
had a significantly increased risk of death compared to
children from 1 month to 12 years of age.
Discussion
We studied the performance of PIM-2 in a large sample
of patients admitted during 2009–2011 to three PICUs
and one CICU of a large tertiary pediatric hospital in
Table 2 Model fit and discrimination by type of unit, main reason for PICU/CICU admission, year and age class
Observed mortality Expected mortality SMR ROC curve
(PIM-2 standardized)
N % 95% CI N % 95% CI SMR 95% CI AUC 95% CI
Unit
CICU 54 4.0 (3.0 - 5.2) 88.8 6.6 (5.3 - 8.0) 0.6 (0.5 - 0.8) § 0.72 (0.65 - 0.80)
PICU1 29 5.4 (3.6 - 7.6) 49.1 9.1 (6.8 - 11.9) 0.6 (0.4 - 0.9) # 0.76 (0.66 - 0.85)
PICU2 38 5.5 (3.9 - 7.4) 35.6 5.5 (3.6 - 7.1) 1.1 (0.8 - 1.5) 0.85 (0.78 - 0.92)
PICU3 8 2.5 (1.1 - 4.9) 13.0 4.0 (2.2 - 6.8) 0.6 (0.3 - 1.2) 0.91 (0.80 - 1.00)
Main reason for PICU/CICU admission
Cardiac surgical 37 3.3 (2.3 – 4.4) 73.0 6.4 (5.1 – 8.0) 0.5 (0.4 – 0.7) § 0.72 (0.63 – 0.82)
Other surgical 28 2.9 (2.0 – 4.2) 26.4 2.7 (1.8 – 4.0) 1.1 (0.7 – 1.5) 0.85 (0.77 – 0.93)
Medical 64 7.8 (6.1 – 9.9) 87.0 10.6 (8.6 – 12.9) 0.7 (0.6 – 0.9) * 0.76 (0.69 – 0.82)
Year
2009 48 4.7 (3.5 - 6.2) 69.1 6.7 (5.3 - 8.5) 0.7 (0.5 - 0.9) # 0.81 (0.74 - 0.88)
2010 47 4.4 (3.3 - 5.8) 65.3 6.1 (4.7 - 7.7) 0.8 (0.5 - 0.9) * 0.82 (0.76 - 0.88)
2011 34 4.1 (2.9 - 5.7) 51.9 6.3 (4.8 - 8.2) 0.7 (0.4 - 0.9) * 0.73 (0.63 - 0.80)
Age class
Newborn (0-7d) 26 10.4 (6.9 - 14.8) 20.3 8.0 (4.9 - 12.0) 1.3 (0.8 - 1.9) 0.74 (0.66 - 0.83)
Neonate (8-30d) 11 6.3 (3.2 - 11.0) 14.1 8.0 (4.4 - 13.1) 0.8 (0.4 - 1.4) 0.79 (0.66 - 0.92)
Infant (1-12 m) 31 3.8 (2.6 - 5.4) 49.7 6.1 (4.6 - 8.0) 0.6 (0.4 - 0.9) # 0.69 (0.58 - 0.80)
Preschool (1-5y) 26 2.8 (1.9 - 4.1) 55.3 6.0 (4.5 - 7.7) 0.5 (0.3 - 0.7) § 0.84 (0.74 - 0.93)
School (6-12y) 15 3.5 (2.0 - 5.6) 26.8 6.2 (4.1 - 8.9) 0.6 (0.3 - 0.9) * 0.84 (0.76 - 0.92)
Adolescent (13-16y) 20 6.2 (3.8 - 9.4) 20.2 6.2 (3.8 - 9.4) 1.0 (0.6 - 1.5) 0.87 (0.79 - 0.95)
Total 129 4.4 (3.7 - 5.2) 186.4 6.4 (5.5 - 7.3) 0.7 (0.6 - 0.8) § 0.79 (0.75 - 0.83)
*: observed versus expected deaths; p < 0.05.
#: observed versus expected deaths; p < 0.01.
§: observed versus expected deaths; p < 0.001.
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Figure 1 Receiving operating characteristic curve; entire
cohort.
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the PIM-2 score is easy to apply and includes variables
easily available at admission to intensive care. PIM-2
appeared to have a fair discriminating ability, with an
overall AUC of 0.8. However, calibration as assessed by
Hosmer-Lemeshow goodness of fit test was less satisfac-
tory, with statistically significant overprediction of deaths
in the total sample, mainly due to the over two-fold
overprediction in the highest risk group.
Similar findings were reported by other Authors
[11,15-17], and variably attributed to differences in the
characteristics of the study population, small sample
size, particularly for number of deaths, and improvement
in the quality of intensive care making the original PIM-
2 equation, developed about ten years ago, no longer
fully appropriate.
Poor calibration by risk groups was not observed in
the multicentric study validating PIM-2 for the Italian
population [10]. This validation study was conducted in
2004–2005, and we cannot exclude that quality of care
has further improved since then. Additionally, that study
included 18 between pediatric and general hospitals with
Table 3 Hosmer-Lemeshow goodness of fit test for groups of mortality risk; entire cohort
ALL (HL chi2 [10]`1 = 68.0; p < 0.001)
Group of risk N Obs % Exp % HL SMR 95% CI P-value
0.000 - 0.003 291 2 (0.7) 0.6 (0.2) 3.2 3.3 (0.4 - 11.9) NS
0.003 - 0.006 291 0 (0.0) 1.2 (0.4) 1.2 0.0 (0.0 - 3.0) NS
0.006 - 0.010 291 5 (1.7) 2.2 (0.8) 3.4 2.2 (0.7 - 5.2) NS
0.010 - 0.014 291 7 (2.4) 3.4 (1.2) 4.0 2.1 (0.8 - 4.3) NS
0.014 - 0.018 292 6 (2.1) 4.6 (1.6) 0.4 1.3 (0.5 - 2.9) NS
0.018 - 0.025 291 7 (2.4) 6.1 (2.1) 0.1 1.2 (0.5 - 2.4) NS
0.025 - 0.035 291 6 (2.1) 8.5 (2.9) 0.8 0.7 (0.3 - 1.5) NS
0.035 - 0.066 291 13 (4.5) 14.1 (4.9) 0.1 0.9 (0.5 - 1.6) NS
0.066 - 0.175 291 30 (10.3) 30.9 (10.6) 0.0 1.0 (0.7 - 1.4) NS
0.175 - 1.000 292 53 (18.2) 114.7 (39.3) 54.7 0.5 (0.4 - 0.6) < 0.001
Total 2,912 129 (4.4) 186.4 (6.4) 68.0 0.7 (0.6 - 0.8) < 0.001
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ered are likely to have been less homogeneous in a such
large sample of different hospitals than between the
ICUs of a single hospital entirely dedicated to the care
of children.
In our study, overprediction of deaths was however
particularly evident among cardiac surgical admissions,
where the number of expected deaths in the highest risk
group was approximately four times higher than ob-
served. These results are in agreement with those found
by Czaja et al. in their study of cardiac surgical pediatric
patients in 55 US PICU in 2005–07 [11]. The mortality
reported by this study (3.4%) was very close to the 3.3%
rate observed in our population of children who under-
went cardiac procedures. Also discrimination was similar
in the two studies, with AUC values of 0.72 (CI 0.63-
0.82) in Italy, and 0.80 (95% CI, 0.77– 0.83) in US, whileTable 4 Logistic multivariable analysis of factors
associated with risk of death
OR 95% CI P-value
PIM-2 score 53.2* (25.2- 112.7) < 0.001
Main reason for PICU/CICU admission 0.009
Medical Ref. -
Other surgical 0.7 (0.4 – 1.1)
Cardiac surgical 0.5 (0.3 – 0.8)
Age class < 0.001
Newborn (0-7d) 3.7 (2.0 – 6.8)
Neonate (8-30d) 2.3 (1.0 – 5.0)
Infant (1-12 m) 1.5 (0.9 – 2.6)
Preschool (1-5y) Ref. -
School (6-12y) 1.3 (0.7 – 2.5)
Adolescent (13-16y) 2.2 (1.2 – 4.2)
* for each incremental point of PIM-2 value.
Ref: reference group.standardised mortality rates were 0.5 (CI 0.4-0.7) and 0.8
(0.7–0.9), respectively.
In our hospital cardiac and cardiac surgical patients
are treated in a separate intensive care Unit (CICU),
characterized by highly specialized dedicated staff and
high activity volume. Consistency between our results
and those by Czaja et al. [11] suggests that PIM-2 cali-
bration for cardiac surgical patients may indeed be sub-
optimal. The development of a specific algorithm for
predicting the risk of death in this highly selected cat-
egory of patients would thus be helpful.
At the light of the statistically significant differences in
observed mortality found between Units, main reasons
of admission to intensive care and patient age class, we
performed a multivariable analysis to simultaneously ex-
plore the effect of these variables on risk of death,
adjusting for PIM2 score. In fact, SMRs did vary by Unit,
and different Units admitted patients with different age
distribution and main reason for admission. It was then
of interest to investigate whether in our patient popula-
tion these variables and the Unit of admission may have
a significant influence on mortality in excess to the pro-
portion predicted by PIM-2 score.
We found that, independently from PIM-2, main rea-
son for admission and age remain significant predictors
of the observed mortality, with lower risk in cardiac sur-
gical patients and in children from 1 month to 12 years
of age, and higher risk in medical patients and in babies
< 1 month of age or adolescents. It is interesting to note
that the two Units with SMRs significantly lower than 1
admitted mostly patients in the cardiac surgical group
(CICU) or from 1 month to 12 years of age (PICU1),
confirming the importance of differences of patient case-
mix.
The lower risk in cardiac surgical patients supports
the importance of cardiac focused risk adjustment. The
role of age on risk of death needs to be further explored.
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http://www.biomedcentral.com/1471-2431/13/100In our study, the observed mortality was higher in the
first month of life and in adolescents. In these age
groups, the PIM-2 standardized mortality was very close
to the observed mortality, while it was significantly lower
in children from 1 month to 12 years of age. The highest
risk of dying in newborns, neonates and adolescents
observed in multivariate analysis could be due to differ-
ences in outcome independent from patients severity at
PICU/CICU admission. In fact, both patients < 1 month
of age and adolescents have specific characteristics, and
could require a more targeted care. Babies < 1 month of
age requiring intensive care can also be treated in
neonatal Intensive Care Units (NICU). It would thus be
relevant to compare PIM-2 performance and SMRs in
newborns and neonates admitted in NICUs versus
PICUs. Teenagers are different from both adults and
pre-adolescent children and, as such, require special
attention in the manner in which healthcare services are
provided. However, there are no standards to guide the
model of care that should be provided specifically for
teenagers in intensive care [18].
Potential limitations of this study should be taken into
account. Data regarding the main diagnosis were derived
from patients’ medical record at discharge, and mis-
classification cannot be completely excluded. However,
in our hospital all clinical records are independently
reviewed at discharge by a second physician, who verifies
the appropriateness of diagnoses and procedures coding.
We derived main reason for PICU/CICU admission
from routinely collected data, and more detailed infor-
mation on reason for intensive care admission was not
available. Data related to PIM-2 were collected prospect-
ively by intensive care physicians at time of admission,
and rates of completeness were very high both on total
patients (91%) and deaths (95%).
Conclusions
In our study, PIM-2 appeared to have a fair discriminat-
ing ability. As other Authors have reported, however,
calibration of the score was suboptimal, mainly because
of the over two-fold overprediction of deaths in the
highest risk group (114.7 vs 53; p < 0.001), and particu-
larly in cardiac-surgical patients. A new calibration study
of PIM-2 score might be needed to take into account
improvements in quality of care occurred during the last
decade. More appropriate cardiac-focused risk-adjustment
models for these patients should also be developed.
Given the independent role of main reason of admission
and age on mortality risk, the proportion of cardiac
surgical patients and patient age distribution should be
considered in interpreting SMRs estimated by different
Units by applying the PIM-2 prediction model, as vari-
able case-mix could distort the overall results and bias
comparisons [19].Competing interests
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